International Leukemia Target Board

RecruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

December 31, 2022

Primary Completion Date

July 1, 2030

Study Completion Date

June 1, 2032

Conditions

Relapsed Hematologic MalignancyRefractory Hematologic Malignancy

Interventions

OTHER

Advice

non-interventional study

Trial Locations (1)

RECRUITING

Princess Máxima Center for Pediatric Oncology, Utrecht

All Listed Sponsors

lead

Princess Maxima Center for Pediatric Oncology

OTHER